Akili Interactive, a company that treats attention-deficit disorders with its video games, will go public by merging with a blank-check firm led by serial dealmaker Chamath Palihapitiya in a deal ...
A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
In addition to PureTech’s advanced Wholly Owned Pipeline, Founded Entities are an additional source of value and Akili is now set to join the growing list of publicly-traded Founded Entities for ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq:PRTC, LSE:PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, today announced ...
Less than two years after scoring its first FDA clearance, Akili Interactive is betting big on its digital therapeutic technology. The Massachusetts-based company has signed a reverse-merger deal with ...
With preparations for the commercial rollout of its first prescription digital therapeutic well underway, Akili Interactive is now turning its attention to other neurological conditions that its ...
Akili Interactive, a digital medicine company, is going public via special purpose acquisition company (SPAC) merger. The roughly $1 billion-dollar deal will see the healthcare company merge with ...
Digital therapeutics maker Akili Interactive Labs today announced a deal with the University of California’s governing board concerning exclusive licensing of a new technology that will combine the ...
Shares in Social Capital Suvretta Holdings (NASDAQ:DNAA) rose sharply on news it completed its merger with Akili Interactive, which hopes to treat brain conditions using video games. After the market ...
Akili Interactive (“Akili” or the “Company”), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered into a definitive agreement to become ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company announces today that its Founded Entity, Akili ...